CLARIVATE PLC (CLVT)

JE00BJJN4441 - Common Stock

6.95  +0.04 (+0.58%)

After market: 6.95 0 (0%)

Buy % Consensus

78

ChartMill assigns a Buy % Consensus number of 78% to CLVT. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 8.56. This target is 23.12% above the current price.
CLVT was analyzed by 16 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about CLVT.
In the previous month the buy percentage consensus was at a similar level.
CLVT was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 6.956.068.678.5610.50 - -12.81% 24.75% 23.12% 51.08%
Up and Down Grades
Date Firm Action Rating
2024-02-28 Oppenheimer Maintains Outperform -> Outperform
2024-02-28 RBC Capital Maintains Sector Perform -> Sector Perform
2024-02-28 Barclays Maintains Underweight -> Underweight
2024-02-28 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2024-01-08 Oppenheimer Maintains Outperform -> Outperform
2023-12-15 Wells Fargo Downgrade Equal-Weight -> Underweight
2023-10-05 Oppenheimer Maintains Outperform -> Outperform
2023-09-26 Citigroup Maintains Neutral -> Neutral
2023-09-08 Barclays Downgrade Equal-Weight -> Underweight
2023-08-25 RBC Capital Downgrade Outperform -> Sector Perform
2023-08-07 B of A Securities Downgrade Neutral -> Underperform
2023-08-04 Oppenheimer Maintains Outperform -> Outperform
2023-08-04 RBC Capital Maintains Outperform -> Outperform
2023-08-04 Barclays Maintains Equal-Weight -> Equal-Weight
2023-08-04 Wells Fargo Downgrade Overweight -> Equal-Weight
2023-08-04 Goldman Sachs Maintains Buy -> Buy
2023-08-04 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2023-07-05 Oppenheimer Maintains Outperform -> Outperform
2023-06-13 Oppenheimer Initiate Outperform
2023-05-10 Goldman Sachs Maintains Buy
2023-05-10 Morgan Stanley Maintains Equal-Weight
2023-04-17 RBC Capital Reiterate Outperform
2023-03-10 RBC Capital Reiterate Outperform
2023-03-02 RBC Capital Maintains Outperform
2023-03-02 Wells Fargo Maintains Overweight
2023-02-06 Morgan Stanley Downgrade Overweight -> Equal-Weight
2023-01-04 Morgan Stanley Maintains Overweight
2022-11-09 RBC Capital Maintains Outperform
2022-11-09 Wells Fargo Maintains Overweight
2022-11-09 Goldman Sachs Maintains Buy